Triplet therapy with darolutamide and docetaxel for metastatic castration-sensitive prostate cancer: a multicenter real-world studyIbuki Tsuru, Haruki Kume, Ryo Tanaka et al.|Japanese Journal of Clinical Oncology|2026Cited by 0